Oracle, Cleveland Clinic, and G42 Announce Strategic Partnership to Launch AI-Based Global Healthcare Delivery Platform
Oracle (ORCL), Cleveland Clinic, and G42 have announced a strategic partnership to develop an AI-powered healthcare delivery platform. The initiative will leverage Oracle Cloud Infrastructure, Oracle AI Data Platform, and Oracle Health applications, combined with Cleveland Clinic's clinical expertise and G42's AI capabilities.
The platform aims to revolutionize healthcare delivery by enabling real-time analysis of population health data, enhancing clinical intelligence at the point of care, and improving both patient outcomes and cost efficiency. Key features include AI-driven diagnostics, personalized treatments, and improved clinical trial processes. The platform will initially launch in the U.S. and UAE, focusing on creating a scalable and cost-effective care model.
The collaboration, currently under a non-binding agreement, builds upon existing partnerships between G42 and Cleveland Clinic through Cleveland Clinic Abu Dhabi.
Oracle (ORCL), Cleveland Clinic e G42 hanno annunciato una partnership strategica per sviluppare una piattaforma per l'assistenza sanitaria potenziata dall'intelligenza artificiale. L'iniziativa sfrutterà Oracle Cloud Infrastructure, Oracle AI Data Platform e le applicazioni Oracle Health, unendo l'expertise clinica della Cleveland Clinic alle capacità AI di G42.
La piattaforma punta a rivoluzionare l'erogazione delle cure sanitarie consentendo l'analisi in tempo reale dei dati sulla salute della popolazione, migliorando l'intelligenza clinica direttamente al punto di cura e ottimizzando sia i risultati per i pazienti sia l'efficienza dei costi. Tra le principali caratteristiche figurano diagnosi guidate dall'AI, trattamenti personalizzati e processi migliorati per le sperimentazioni cliniche. Il lancio iniziale avverrà negli Stati Uniti e negli Emirati Arabi Uniti, con l'obiettivo di creare un modello di assistenza scalabile e sostenibile economicamente.
La collaborazione, attualmente basata su un accordo non vincolante, si fonda su partnership già esistenti tra G42 e Cleveland Clinic tramite la Cleveland Clinic Abu Dhabi.
Oracle (ORCL), Cleveland Clinic y G42 han anunciado una alianza estratégica para desarrollar una plataforma de atención sanitaria impulsada por inteligencia artificial. Esta iniciativa aprovechará Oracle Cloud Infrastructure, Oracle AI Data Platform y las aplicaciones Oracle Health, combinadas con la experiencia clínica de Cleveland Clinic y las capacidades de IA de G42.
La plataforma tiene como objetivo revolucionar la prestación de servicios de salud mediante el análisis en tiempo real de datos de salud poblacional, mejorando la inteligencia clínica en el punto de atención y optimizando tanto los resultados para los pacientes como la eficiencia en costos. Entre sus características principales se incluyen diagnósticos impulsados por IA, tratamientos personalizados y procesos mejorados para ensayos clínicos. El lanzamiento inicial será en EE. UU. y Emiratos Árabes Unidos, enfocándose en crear un modelo de atención escalable y rentable.
La colaboración, que actualmente se basa en un acuerdo no vinculante, se fundamenta en asociaciones previas entre G42 y Cleveland Clinic a través de Cleveland Clinic Abu Dhabi.
Oracle (ORCL), Cleveland Clinic, 그리고 G42가 AI 기반 헬스케어 제공 플랫폼 개발을 위한 전략적 파트너십을 발표했습니다. 이번 이니셔티브는 Oracle Cloud Infrastructure, Oracle AI Data Platform, Oracle Health 애플리케이션과 Cleveland Clinic의 임상 전문성, G42의 AI 역량을 결합합니다.
이 플랫폼은 인구 건강 데이터의 실시간 분석을 가능하게 하여 의료 현장에서의 임상 지능을 향상시키고 환자 결과와 비용 효율성을 모두 개선함으로써 헬스케어 제공 방식을 혁신하는 것을 목표로 합니다. 주요 기능으로는 AI 기반 진단, 개인 맞춤 치료, 임상 시험 프로세스 개선이 포함됩니다. 플랫폼은 미국과 UAE에서 처음 출시되며, 확장 가능하고 비용 효율적인 치료 모델 구축에 중점을 둡니다.
현재 비구속적 합의 하에 진행 중인 이번 협력은 Cleveland Clinic Abu Dhabi를 통한 G42와 Cleveland Clinic 간 기존 파트너십을 기반으로 합니다.
Oracle (ORCL), Cleveland Clinic et G42 ont annoncé un partenariat stratégique pour développer une plateforme de soins de santé alimentée par l'IA. Cette initiative tirera parti d'Oracle Cloud Infrastructure, d'Oracle AI Data Platform et des applications Oracle Health, combinées à l'expertise clinique de la Cleveland Clinic et aux capacités en IA de G42.
La plateforme vise à révolutionner la prestation des soins de santé en permettant une analyse en temps réel des données de santé de la population, en améliorant l'intelligence clinique au point de soins et en optimisant à la fois les résultats pour les patients et l'efficacité des coûts. Parmi les principales fonctionnalités figurent des diagnostics pilotés par l'IA, des traitements personnalisés et des processus améliorés pour les essais cliniques. Le lancement initial se fera aux États-Unis et aux Émirats arabes unis, avec un focus sur la création d'un modèle de soins évolutif et rentable.
Cette collaboration, actuellement basée sur un accord non contraignant, s'appuie sur les partenariats existants entre G42 et la Cleveland Clinic via la Cleveland Clinic Abu Dhabi.
Oracle (ORCL), Cleveland Clinic und G42 haben eine strategische Partnerschaft zur Entwicklung einer KI-gestützten Gesundheitsplattform bekannt gegeben. Die Initiative nutzt Oracle Cloud Infrastructure, Oracle AI Data Platform und Oracle Health-Anwendungen in Kombination mit der klinischen Expertise der Cleveland Clinic und den KI-Fähigkeiten von G42.
Ziel der Plattform ist es, die Gesundheitsversorgung zu revolutionieren, indem sie eine Echtzeitanalyse von Bevölkerungsdaten ermöglicht, die klinische Intelligenz am Ort der Behandlung verbessert und sowohl Patientenergebnisse als auch Kosteneffizienz steigert. Zu den Hauptmerkmalen gehören KI-gestützte Diagnostik, personalisierte Behandlungen und verbesserte klinische Studienprozesse. Der Start erfolgt zunächst in den USA und den VAE mit Fokus auf ein skalierbares und kosteneffizientes Versorgungsmodell.
Die Zusammenarbeit basiert derzeit auf einer unverbindlichen Vereinbarung und baut auf bestehenden Partnerschaften zwischen G42 und der Cleveland Clinic über die Cleveland Clinic Abu Dhabi auf.
- Partnership combines Oracle's cloud infrastructure and AI capabilities with Cleveland Clinic's clinical expertise and G42's AI technology
- Platform aims to reduce healthcare costs while improving care quality and patient outcomes
- Will enable better clinical trial candidate identification and enrollment at point of care
- Creates opportunities for expansion in both U.S. and UAE healthcare markets
- Agreement is currently non-binding, indicating uncertainty in final implementation
- Complex integration of multiple systems and stakeholders could present execution challenges
- No specific timeline or financial details provided for platform implementation
Insights
Oracle's three-way partnership creates a promising AI healthcare platform, though commercial success depends on effective implementation and regulatory navigation.
This strategic partnership between Oracle Health, Cleveland Clinic, and G42 represents a significant move in the healthcare AI space. Oracle is contributing its Cloud Infrastructure, AI Data Platform, and Health applications - essentially deploying its full technology stack to power this initiative. The combination with Cleveland Clinic's clinical expertise and G42's AI capabilities creates a formidable collaboration.
The technical architecture described here is ambitious - a platform designed to analyze population health data in real-time while providing point-of-care clinical intelligence. This positions Oracle to potentially capture significant value in the rapidly growing healthcare AI market, estimated to reach
What stands out is the dual-market approach, targeting both the U.S. and UAE initially. This gives Oracle access to two very different healthcare ecosystems - the complex, fragmented U.S. system and the more centralized UAE system where implementation could potentially move faster.
The platform aims to address several critical healthcare pain points: rising costs, aging populations, and chronic disease management. The integration between clinical research and care delivery is particularly noteworthy, as it could accelerate clinical trials and create additional revenue streams.
However, the non-binding nature of this agreement is an important detail. This suggests the partnership remains in early stages, with execution risks ahead. Healthcare AI implementations face significant challenges including data integration complexity, regulatory hurdles, and clinician adoption. Oracle will need to navigate these carefully to transform this partnership into material revenue growth.
The Oracle-Cleveland Clinic-G42 partnership represents a significant development in healthcare's AI transformation landscape. This collaboration strategically positions all three entities at the intersection of several powerful healthcare trends: AI integration, data sovereignty, and value-based care models.
From a healthcare systems perspective, what makes this partnership potentially transformative is its explicit focus on simultaneously improving care quality while reducing costs - the holy grail of healthcare reform. The platform appears designed to address the fundamental misalignment of incentives that has historically plagued healthcare systems worldwide.
Cleveland Clinic brings crucial clinical credibility to this venture. As one of the most respected academic medical centers globally, their involvement suggests the platform will likely prioritize evidence-based approaches rather than simply automating existing processes. This clinical grounding is essential for adoption among healthcare professionals who remain skeptical of AI applications.
The UAE component is particularly interesting as it offers a testing ground with fewer regulatory hurdles than the U.S. healthcare system. The UAE has demonstrated willingness to rapidly implement healthcare innovations, potentially allowing the partnership to iterate quickly before scaling solutions to more complex markets.
However, the platform will face significant challenges around data governance, privacy regulations that vary across jurisdictions, and the need to demonstrate measurable improvements in patient outcomes to justify adoption costs. The non-binding nature of the agreement also signals that significant details remain to be worked out.
If successful, this platform could accelerate the shift from fee-for-service to value-based care models by giving providers the analytical tools needed to manage population health effectively while controlling costs.
Partnership will build a global AI-powered healthcare platform to deliver more effective, scalable, and affordable care
The platform will serve as the foundation for an AI-driven healthcare hub, combining Oracle Cloud Infrastructure, Oracle AI Data Platform, and Oracle Health applications, Cleveland Clinic's world-class clinical expertise, and G42's capabilities in sovereign AI infrastructure, health data integration, and advanced clinical AI models. Designed to meet the evolving needs of global populations, starting with the
Powering the hospital of the future
Fully AI-enabled health systems will continually analyze population and public health data in real-time, providing practitioners with clinical intelligence at the point of care. Clinicians and public health administrators will also gain deeper insights into the well-being of patient populations at scale and the factors that may be contributing to disease progression and poor outcomes. The platform will also enable organizations to simultaneously improve care quality while driving down costs by finally giving both clinical and operational executives the data, analyses, and predictive capabilities they need to improve patient and financial outcomes.
In tandem, the collaboration will help drive a new era of life sciences innovation by removing the silos between clinical research and clinical care. Providers will be able to more easily identify clinical trial candidates and enroll them in appropriate studies at the point of care. Researchers will be able to access invaluable real-world data to detect opportunities for therapeutic intervention and closely monitor the performance and effects of existing and new therapies to limit risk, support patient safety, and get life-saving new treatments to market faster.
The platform will:
- Deliver an AI-driven healthcare infrastructure rooted in data privacy, clinical quality, and operational efficiency.
- Establish a scalable and cost-effective care model that positions the
U.S. andUAE as co-leaders in supporting next-generation healthcare solutions. - Use AI to enhance diagnostics, personalize treatments, optimize outcomes, and reduce costs at scale.
- Deliver high-quality, affordable care worldwide, addressing the rising pressures of aging populations and chronic diseases.
"Aging populations, rising costs, and the complexity of care demand a complete reinvention of how healthcare is provided," said Oracle Executive Chairman and CTO Larry Ellison. "Oracle's AI Data Platform and suite of clinical applications can help us understand disease and population health in ways that fuel scientific breakthroughs, reduce the cost of care delivery, and improve patient care. Together with Cleveland Clinic and G42, we will deliver the modern tools providers need to help people live longer, healthier lives."
"This venture represents a bold leap forward in our collective mission to transform how healthcare is delivered. As a leader in healthcare, it is a moral imperative to create solutions that benefit the health and wellness of people," said Tom Mihaljevic, MD, President and CEO, and Morton C. Mandel CEO Chair of Cleveland Clinic. "An AI-enabled model of care could positively impact global health systems - a flagship example of how data-driven, tech-powered healthcare can deliver better outcomes, lower costs, and expand access worldwide."
"At the intersection of life-saving science and transformative technology lies our greatest opportunity to redefine the future of health. This partnership between Cleveland Clinic, Oracle Health, and G42 signals the strength of the UAE–US technology corridor, and our shared resolve to build a new health intelligence fabric," said Peng Xiao, Group CEO at G42. "Together, we are advancing a model of care defined by precision, sovereignty, equity, and longevity for all."
This partnership is set to become the standard of how public-private collaboration and data-driven innovation can help dramatically improve healthcare outcomes while making care more affordable and accessible. Together, Oracle, Cleveland Clinic, and G42 will reshape the future of health for generations to come.
G42 and Cleveland Clinic have already established a strong collaboration through Cleveland Clinic Abu Dhabi and the
The collaboration between Cleveland Clinic, G42, and Oracle is part of a non-binding agreement.
About G42
G42 is a technology holding group, a global leader in creating visionary artificial intelligence for a better tomorrow. Born in
For more information, please contact TrailRunner International: G42@trailrunnerint.com
About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at oracle.com.
For more information, please contact Greg Lunsford, Oracle Communications, greg.lunsford@oracle.com.
Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in
Editor's Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.
View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-cleveland-clinic-and-g42-announce-strategic-partnership-to-launch-ai-based-global-healthcare-delivery-platform-302457708.html
SOURCE G42
FAQ
What is the purpose of Oracle's partnership with Cleveland Clinic and G42?
How will ORCL's AI healthcare platform benefit patients?
What technologies will Oracle use in this healthcare partnership?
Where will Oracle's AI healthcare platform be initially launched?
How will this partnership affect clinical trials and research?
